| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $83.3M | -3.2% | -15.6% |
| Cost of Revenue | $17.1M | -4.4% | +40.8% |
| Gross Profit | $66.1M | -2.9% | -23.5% |
| R&D Expense | $14.0M | -4.9% | -13.9% |
| SG&A Expense | $22.5M | +0.9% | +8.9% |
| Operating Income | $2.4M | +91.1% | -88.6% |
| Interest Expense | $3.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $223.3M | -10.9% | -34.6% |
| Accounts Receivable | $212.8M | +1.8% | -6.6% |
| Current Assets | $455.5M | -5.6% | -20.9% |
| Total Assets | $569.4M | -5.2% | -4.8% |
| Current Liabilities | $206.5M | +1.2% | -2.3% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $67.5M | — | — |
| Capital Expenditures | $12.8M | — | — |
| Investing Cash Flow | -$23.1M | — | — |
| Financing Cash Flow | -$170.7M | — | — |
| Free Cash Flow | $54.7M | — | — |
| — |
| +9130.8% |
| Pre-tax Income | $5.3M | +35.8% | -79.1% |
| Income Tax | $3.7M | +169.9% | -52.9% |
| Net Income | $1.5M | -38.4% | -91.1% |
| EPS (Basic) | $0.05 | -44.4% | -91.1% |
| EPS (Diluted) | $0.05 | -37.5% | -90.2% |
| $239.8M |
| -2.8% |
| +8.9% |
| Stockholders' Equity | $329.6M | -6.9% | -12.8% |